Search
Atopic Dermatitis Paid Clinical Trials in Idaho
A listing of 8 Atopic Dermatitis clinical trials in Idaho actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 8 of 8
The state of Idaho currently has 8 active clinical trials seeking participants for Atopic Dermatitis research studies. These trials are conducted in various cities, including Boise, Meridian, Idaho Falls and Nampa.
Featured Trial
Atopic Dermatitis (Eczema) Study
Recruiting
The purpose of this clinical study is to see whether an investigational injectable medication can help to treat symptoms of moderate to severe Atopic Dermatitis (eczema). You may qualify to participate if you were diagnosed with Atopic Dermatitis at least 1 year ago and are currently experiencing symptoms. Participants who qualify for the study will receive trial-related procedures and study medication at no cost. The site staff can provide you with additional details.
Conditions:
Atopic Dermatitis
Dermatitis
Atopic
Atopic Dermatitis Eczema
Atopic Eczema
* Compensation for time may be available
Featured Trial
Atopic Dermatitis (Eczema) Study
Recruiting
Sign up for a clinical trial today and contribute to the advancement of medical research, paving the way for innovative treatments. Receive financial compensation for your participation and benefit from complimentary medical care.
Featured Trial
Eczema Clinical Study
Recruiting
The purpose of this clinical study is to see whether an oral investigational medication can help to treat symptoms of moderate to severe Atopic Dermatitis (eczema).
Conditions:
Eczema
Atopic Dermatitis Eczema
Atopic Eczema
Eczema
Atopic
* Compensation for time may be available
Featured Trial
Eczema Clinical Trial for Children & Adolsecents
Recruiting
Enrolling candidates diagnosed with Atopic Dermatitis (Eczema). Compensation available.
Conditions:
Atopic Dermatitis
Eczema
Atopic Dermatitis Eczema
Dermatitis
Atopic
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Recruiting
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to <18 years of age with moderate-to-severe atopic dermatitis (AD).
Gender:
All
Ages:
Between 6 months and 17 years
Trial Updated:
04/16/2024
Locations: Treasure Valley Medical Research, Boise, Idaho
Conditions: Atopic Dermatitis, Eczema
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).
Recruiting
This study will evaluate the safety, tolerability, and efficacy of ANB032 in subjects with moderate to severe atopic dermatitis (AD).
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
04/16/2024
Locations: Site 10-130, Boise, Idaho
Conditions: Atopic Dermatitis Eczema
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Recruiting
The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to <18 years of age with moderate-to-severe atopic dermatitis
Gender:
All
Ages:
Between 6 months and 18 years
Trial Updated:
04/14/2024
Locations: Treasure Valley Medical Research, Boise, Idaho
Conditions: Atopic Dermatitis, Eczema
A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe AD
Recruiting
The primary objective of this study is to assess successful self-administration of rocatinlimab subcutaneous using devices for injection at home.
Gender:
All
Ages:
Between 12 years and 100 years
Trial Updated:
04/11/2024
Locations: Treasure Valley Medical Research, Boise, Idaho
Conditions: Atopic Dermatitis
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
Recruiting
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
04/10/2024
Locations: Treasure Valley Medical Research, Boise, Idaho
Conditions: Atopic Dermatitis
A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD)
Recruiting
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subjects.
Gender:
All
Ages:
Between 12 years and 17 years
Trial Updated:
04/10/2024
Locations: Treasure Valley Medical Research, Boise, Idaho +1 locations
Conditions: Atopic Dermatitis
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Recruiting
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Gender:
All
Ages:
Between 12 years and 100 years
Trial Updated:
03/27/2024
Locations: Treasure Valley Medical Research, Boise, Idaho
Conditions: Atopic Dermatitis
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
Recruiting
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atopic Dermatitis.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/16/2024
Locations: Treasure Valley Medical Research, Boise, Idaho
Conditions: Atopic Dermatitis
1 - 8 of 8